lanreotide acetate

{
  "id": "MLC-T-ONC-004709",
  "term": "lanreotide acetate",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug that is similar to somatostatin (a hormone made by the body) and is used to treat certain types of gastroenteropancreatic neuroendocrine tumors, carcinoid syndrome, and acromegaly (a condition in which the pituitary gland makes too much growth hormone). Lanreotide acetate may help stop the body from making extra amounts of certain hormones, including growth hormone, insulin, glucagon, and hormones that affect digestion. It may also help keep certain types of tumor cells from growing. Lanreotide acetate is a type of somatostatin analog. Also called Somatuline Depot.",
    "The acetate salt of a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and also to SSTR-5 with a lesser affinity. However, compared to octreotide, this agent is less potent in inhibiting the release of growth hormone from the pituitary gland. Furthermore, lanreotide has an acute effect on decreasing circulating total and free insulin-like growth factor 1 (IGF-I). This agent is usually given as a prolonged-release microparticle or Autogel formulation for the treatment of acromegaly and to relieve the symptoms of neuroendocrine tumors."
  ],
  "synonyms": [
    "Somatuline Depot"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/lanreotide-acetate/"
}